| abstract |
The present invention further provides a method of preparing nanocrystals of a hydrophobic therapeutic agent such as fluticasone or triamcinolone, pharmaceutical compositions (e.g., topical or intranasal compositions) thereof and methods for treating and / or preventing the signs and / or symptoms of disorders such as blepharitis, dysfunction of the Meibomian glands or inflammation of the skin or a respiratory disease (for example, asthma). |